This $NUTX short report rehashes the old July short report without providing any new information. It is clearly written by an outsider who doesn't understand that the QPA rate is close to the Medicare rate, while the private in-network rate is 2-4x higher than the Medicare rate.

Watch CEO Dr. Tom Vo discuss the unit economics behind $NUTX lower-cost ER model and a 12-month breakeven timeline for a new micro-hospital. He also shares how the expansion targets blue-collar communities like Sherman, TX amid the AI chip-factory boom.

@smallmidcaps @jinacapital Uses aquablation therapy

@smallmidcaps The QPA is generally the median in-network rate. https://t.co/ErviXg8ha1

Avui hem participat en la conferència de la Comissió @EP_SingleMarket sobre l’estratègia del Mercat Únic. ✅ Des de @SMEunited han exposat les demandes de les #pimes i la necessitat de diferenciar-les de les #smallmidcaps.

@FrameworkWisely what do you think about $lfmd now? nvo ceo mentioned it as one of the partners to sell the new pill. i recall you knew a lot about the company.

Der Plutos-Schweiz Fund kann in der kurzen Woche mit +4.7% erneut zulegen. Überflieger der Woche waren Kuros Biosciences und ams OSRAM. https://t.co/Um1O9pjbed #solacapital #schweizeraktien #investmentfunds #investmentadvice #börse #management #smallmidcaps

📰 𝐀𝐁𝐄𝐎, 𝐜𝐡𝐨𝐬𝐞 𝐩𝐫𝐨𝐦𝐢𝐬𝐞, 𝐜𝐡𝐨𝐬𝐞 𝐝𝐮𝐞 ! Dans son analyse pour Investir, Céline Panteix souligne la capacité d’ABEO à tenir ses engagements et à poursuivre sa trajectoire de croissance https://t.co/nCDlrRK81m #ABEO #Investir #LesEchos #Analyse #SmallMidCaps

$NUTX When is the short coming? Hopefully when he has something better than that lazy effort Meanwhile, I'll continue to make money. It's not personal, but I'm in the business of outperformance

@footletica @MichaelWigginsO what do i think about $afrm vs $sezl at today’s prices? the latter seems to be the cheaper one with higher growth estimates, right?

@RyshabTalks @Spiralout_one Thank you! I only started investing in small and mid caps in 2024, so I know I still have a lot to learn and that any speculative premium in my holdings could fade quickly if the market turns. I also appreciate you sharing new tickers. I always research them whenever you post.

@smallmidcaps @warrwim Would be awesome if the official account of the US department of energy would get basic energy facts right.

in $TMDX discord, along with @AndrewP64090323, I and @smallmidcaps also listened majority of the hearing and we came out more bullish for $TMDX. This may end up benefiting us. Improved Since DCD is growing well, good strict process with protocol will help long term.

@smallmidcaps @Nietschecapital $COIN wins from $CRCL but $COIN print was disappointing

@Spiralout_one @smallmidcaps I agree. Price anchoring is a terrible trait. If your stock is good and will run for 10 years, you have to average up. Imagine using price anchoring mentality on mag 7. Or even these names of today, $alab, $creo, $Ssal, $Dave, $Nbis, $iren

@finfutureX @smallmidcaps @footletica @MichaelWigginsO Based on latest data (as of Dec 2025): AFRM (Affirm): - YoY Revenue Growth: 33.6% (Q1 FY2026, ending 9/30/2025) - Net Income Margin: 6.74% (TTM) - Market Cap: $25.02B SEZL (Sezzle): - YoY Revenue Growth: 67% (Q3 2025) - Net Income Margin: 27.7% (current) - Market Cap: $2.41B

@smallmidcaps Another monster quarter from $NUTX. The company seems to have addressed Blue Orca short sellers accusations. But this name is just too volatile for my taste with no way to hedge either with options.

$NUTX You are too nervous man... the call isn't going to give you anything. What you need is time. Just sit on your hands. The stock market is a way to take from the impatient to the patient.

@smallmidcaps $SEZL is my preferred BNPL.